Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ANGIODYNAMICS INC Director's Dealing 2010

Aug 5, 2010

32939_dirs_2010-08-05_f7bba866-b48c-4014-87ec-a2b064ab0193.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ANGIODYNAMICS INC (ANGO)
CIK: 0001275187
Period of Report: 2010-08-03

Reporting Person: GERSUK D JOSEPH (EVP - CFO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2010-08-03 Common Stock A 15000 Acquired 25651 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2010-08-03 Non-Qualified Stock Option (right to buy) $15.75 A 25000 Acquired 2017-08-03 Common Stock (25000) Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Non-Qualified Stock Option (right to buy) $13.29 2016-09-04 Common Stock (12000) 12000 Direct
Non-Qualified Stock Option (right to buy) $16.33 2015-08-15 Common Stock (12500) 12500 Direct
Non-Qualified Stock Option (right to buy) $16.53 2014-05-01 Common Stock (40800) 40800 Direct
Non-Qualified Stock Option (right to buy) $17.76 2017-07-27 Common Stock (8750) 8750 Direct
Restricted Stock Units $0 2014-05-01 Common Stock (1126) 1126 Direct
Restricted Stock Units $0 2016-09-04 Common Stock (12000) 12000 Direct

Footnotes

F1: Options for 25% of the total number of shares each become exercisable on 8/3/2011, 8/3/2012, 8/3/2013, and 8/3/2014.

F2: Options for 25% of the shares are each exercisable on 5/1/08, 5/1/09, 5/1/10, 5/1/11, respectively.

F3: Options for 25% of the total number of shares each become exercisable on 7/27/08, 7/27/09, 7/27/10, and 7/27/11.

F4: Each restricted stock unit represents a contingent right to receive one share of AngioDynamics, Inc. common stock.